High Prevalence Of Hiv Around The Globe Is Boosting The Growth Of The Toxoplasmosis Treatment Drugs Market

Toxoplasmosis Treatment Drugs Market


 In February 2020, The U.S. Food and Drug Administration has approved an application for the first generic of Daraprim (pyrimethamine) tablets for the treatment of toxoplasmosis (an infection caused by the parasite Toxoplasma gondii) when used with a sulfonamide (a group of medicines used to treat bacterial infections).

The rising prevalence of HIV around the globe is increasing the risk of toxoplasma gonad infection. This is contributing to the growth of the toxoplasmosis treatment drugs market. According to the HIV.gov Mission & Team, there were approximately 38 million people across the globe with HIV/AIDS in 2019. Of these, 36.2 million were adults and 1.8 million were children (<15 years old). Moreover, growing research and development activities by pharma companies for toxoplasmosis are again fostering the growth of the toxoplasmosis treatment drugs market. For example, in 2018, Vyera Pharmaceuticals LLC received the U.S. Food Drug and Administration (FDA) approval to initiate Phase 1 study of the VYR-006, which is a potent dihydrofolate reductase (DHFR) inhibitor used for the treatment of toxoplasmosis.

North America is expected to dominate the global toxoplasmosis treatment drugs market and this is attributed to the high prevalence of increasing prevalence of toxoplasmosis infection in the region. According to the U.S. Department of Health & Human Services, in the United States, it is estimated that 11% of the population 6 years and older have been infected with Toxoplasma. More than 40 million men, women, and children in the U.S. carry the Toxoplasma parasite, but very few have symptoms because the immune system usually keeps the parasite from causing illness.

Toxoplasmosis is an infectious disease caused by a strain of bacteria called Toxoplasma gondii. The infection is caused by the protozoan parasite Toxoplasma gondii. A person with toxoplasmosis infection may have no noticeable symptoms or may exhibit very mild or severe symptoms. Some people may not even show any symptoms of the disease. It is usually acquired through direct contact with the waste material or the secretions of the anus, mouth, or vagina of an infected person. In such cases, there is a high risk of transmitting the infection to the affected person's sexual partner. Common cold, fever, headache, muscle aches, nausea, vomiting, abdominal pain, and diarrhea are some of the symptoms of toxoplasmosis infection. Surgery, chemotherapy, antiviral drugs, and antibiotics are some of the treatment options for toxoplasma 

Comments

Post a Comment

Popular posts from this blog

Astrum Has Expanded Its Presence In India Infrared Thermometer Market

Image
  The Infrared Thermometer market is witnessing the fastest growth in the Asia Pacific region and this can be accredited to the growing aging population in the region which is driving demand for healthcare services. Japan has the highest growing aging population in the country. According to the Statistics Bureau, Ministry of Internal Affairs and Communications, in 2019, the aged population (65 years old and over) was 35.89 million, constituting 28.4 percent of the total population (i.e., 1 in every 4 persons) and marking a record high in Japan. The rise in prevalence of infectious disease and increase in the demand for the product for newborns as children cannot hold the contact thermometer is playing a key role in the overall development of the infrared thermometer market . According to the World Health Organization, HIV, tuberculosis, malaria, neglected tropical diseases, and viral hepatitis affects billions of people around the world and causes more than 4 million deaths each year
Read more

Cfmoto Has Announced The Launch Of Its Electric Concept ATV To Expand Its Business In The Global All-Terrain Vehicle (ATV) Lighting Systems Market

Image
  A growing number of ATV racing events across the globe is driving the growth of the all-terrain vehicle (ATV) lighting systems market . For instance, MX sports have scheduled 10 ATV events for the year 2020. Such racing events are increasing the popularity of ATV bikes and are expected to drive market growth during the forecast period. The growing popularity of ATV across developing countries is again contributing to the growth of the market. For instance, in March 2019, Auto Sports India organized an ATV championship in three categories: Drag race, Solo Dirt Race, and Endurance Race in Goa. Moreover, the growing focus of key players to introduce electric all-terrain vehicles is further projected to augment the growth of the all-terrain vehicle (ATV) lighting systems market. For instance, in December 2018, Ecocharger Company has announced the launch of electric ATV vehicle. North America is expected to hold the global all-terrain vehicle (ATV) lighting systems market and this is
Read more

The Global Meningococcal Vaccines Market Continues To Grow Owing To the Demand from Healthcare Care Sectors across the World to Prevent the Spread of the Diseases Especially In Children

Image
  Meningococcal vaccines prevent the contraction of meningococcal diseases, including meningitis caused by the bacteria called meningococcus aureus. An outbreak of meningococcal disease is usually followed by an onset of meningitis. Meningococcal meningitis can cause permanent damage to the brain or spinal cord in as little as 10 days, depending on the degree of infection and the natural immunity of the person. Since meningitis is usually associated with a fever and signs and symptoms of a serious illness, many parents prefer not to use the traditional treatments for their children such as meningitis or oral antibiotics. Instead, they often resort to various forms of therapeutic interventions that may even improve their chances of developing a positive outcome. Meningococcal vaccines are now available for meningococcal meningitis, as well as for men who have had other prior bouts of meningitis. Some vaccines used for these purposes are PPSV, Rallo, and Q fever type 1. These vaccines
Read more